Philips launch AI imaging and reporting tools to support prostate cancer care
Imaging biomarker specialist Quibim partners with Philips to deliver new AI based imaging and reporting solutions for MR prostate exams while relieving staff shortages.
27 October 2023
27 October 2023
Imaging biomarker specialist Quibim partners with Philips to deliver new AI based imaging and reporting solutions for MR prostate exams while relieving staff shortages.
There are multiple free-to-use applications that give people knowledge regarding their symptoms, and they are all built using different technologies.
The company achieved an adjusted EPS of $0.50 for this quarter, compared to $0.43 a year ago.
Recent data from the COMMENCE aortic trial showed promising outcomes for RESILIA tissue.
The VC firm has invested $20m into Betteromics and $3m into L’école AI, adding to previous investments in AI medtech companies through the strategy.
The NeXT Personal Dx can be used to detect molecular residual disease and monitor immune response in lung and breast cancers.
The collaboration will include technology development, regulatory compliance, sales and worldwide distribution.
Paige Lymph Node can identify the presence of breast cancer metastases with near-perfect sensitivity.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
The Excellence Awards celebrate the greatest achievements and innovations in the industry while providing a platform to recognize the people and companies driving change – get entry details now.
Give your business an edge with our leading industry insights.